These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9611845)

  • 1. Preparation of targeted isoniazid microspheres.
    Bosela AA; el-Sayed MM; Mahmoud MI
    Boll Chim Farm; 1998 Mar; 137(3):77-81. PubMed ID: 9611845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable implants from poly-(alpha-hydroxy acid) polymers for isoniazid delivery.
    Hurley L; Andersen BR
    Int J Tuberc Lung Dis; 1999 Nov; 3(11):1015-24. PubMed ID: 10587324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution test for site-specific release isoniazid pellets in USP apparatus 3 (reciprocating cylinder): optimization using response surface methodology.
    Joshi A; Pund S; Nivsarkar M; Vasu K; Shishoo C
    Eur J Pharm Biopharm; 2008 Jun; 69(2):769-75. PubMed ID: 18191554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofloxacin targeting to lungs by way of microspheres.
    Harsha S; R C; Rani S
    Int J Pharm; 2009 Oct; 380(1-2):127-32. PubMed ID: 19646516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microparticle-based lung delivery of INH decreases INH metabolism and targets alveolar macrophages.
    Zhou H; Zhang Y; Biggs DL; Manning MC; Randolph TW; Christians U; Hybertson BM; Ng KY
    J Control Release; 2005 Oct; 107(2):288-99. PubMed ID: 16009444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of human serum albumin microspheres by a novel acetone-heat denaturation method.
    Chen CQ; Lin W; Coombes AG; Davis SS; Illum L
    J Microencapsul; 1994; 11(4):395-407. PubMed ID: 7931939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs.
    Prabakaran D; Singh P; Jaganathan KS; Vyas SP
    J Control Release; 2004 Mar; 95(2):239-48. PubMed ID: 14980772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stable multiple emulsion system bearing isoniazid: preparation and characterization.
    Khopade AJ; Jain NK
    Drug Dev Ind Pharm; 1998 Mar; 24(3):289-93. PubMed ID: 9876587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalable microparticles containing large payload of anti-tuberculosis drugs.
    Muttil P; Kaur J; Kumar K; Yadav AB; Sharma R; Misra A
    Eur J Pharm Sci; 2007 Oct; 32(2):140-50. PubMed ID: 17681458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable microparticulate system of captopril.
    Dandagi PM; Mastiholimath VS; Patil MB; Gupta MK
    Int J Pharm; 2006 Jan; 307(1):83-8. PubMed ID: 16310990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled microparticles of antitubercular antibiotic for in vitro and in vivo alveolar macrophage targeting and activation of phagocytosis.
    Parikh R; Dalwadi S; Aboti P; Patel L
    J Antibiot (Tokyo); 2014 May; 67(5):387-94. PubMed ID: 24569669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarithromycin targeting to lung: optimization of the size, morphology and release characteristics of albumin microspheres.
    Ozkan Y; Dikmen N; Işimer A
    Acta Pol Pharm; 2000; 57(5):375-80. PubMed ID: 11126029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasonically controlled release and targeted delivery of diclofenac sodium via gelatin magnetic microspheres.
    Saravanan M; Bhaskar K; Maharajan G; Pillai KS
    Int J Pharm; 2004 Sep; 283(1-2):71-82. PubMed ID: 15363503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factorial design based optimization of the formulation of albumin microspheres containing adriamycin.
    Gupta PK; Hung CT; Lam FC
    J Microencapsul; 1989; 6(2):147-60. PubMed ID: 2723957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
    He JT; Tao XM; Mo W; Song HY
    Yao Xue Xue Bao; 2006 Jan; 41(1):12-8. PubMed ID: 16683521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of anti-tuberculosis drug concentration and distribution from sustained release microspheres in the vertebrae of a spinal tuberculosis rabbit model.
    Liu P; Jiang H; Li S; Lin Z; Jiang J
    J Orthop Res; 2017 Jan; 35(1):200-208. PubMed ID: 26996958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies.
    Gavini E; Chetoni P; Cossu M; Alvarez MG; Saettone MF; Giunchedi P
    Eur J Pharm Biopharm; 2004 Mar; 57(2):207-12. PubMed ID: 15018976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained release of isoniazid from polylactide microspheres prepared using solid/oil drug loading method for tuberculosis treatment.
    Zhang L; Li Y; Zhang Y; Zhu C
    Sci China Life Sci; 2016 Jul; 59(7):724-31. PubMed ID: 27278371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiolabeling and evaluation of alginate blend-isoniazid microspheres by 99mTc for the treatment of tuberculosis in rabbit model.
    Samad A; Sultana Y; Khar RK; Aqil M; Kalam MA; Chuttani K; Mishra AK
    J Drug Target; 2008 Jul; 16(6):509-15. PubMed ID: 18604664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.